Abstract
Biofabrication via light-based 3D printing offers superior resolution and ability to generate free-form architectures, compared to conventional extrusion technologies. While extensive efforts in the design of new hydrogel bioinks lead to major advances in extrusion methods, the accessibility of lithographic bioprinting is still hampered by a limited choice of cell-friendly resins. Herein, we report the development of a novel set of photoresponsive bioresins derived from ichthyic-origin gelatin, designed to print high-resolution hydrogel constructs with embedded convoluted networks of vessel-mimetic channels. Unlike mammalian gelatins, these materials display thermal stability as pre-hydrogel solutions at room temperature, ideal for bioprinting on any easily-accessible lithographic printer. Norbornene- and methacryloyl-modification of the gelatin backbone, combined with a ruthenium-based visible light photoinitiator and new coccine as a cytocompatible photoabsorber, allowed to print structures resolving single-pixel features (∼50 μm) with high shape fidelity, even when using low stiffness gels, ideal for cell encapsulation (1–2 kPa). Moreover, aqueous two-phase emulsion bioresins allowed to modulate the permeability of the printed hydrogel bulk. Bioprinted mesenchymal stromal cells displayed high functionality over a month of culture, and underwent multi-lineage differentiation while colonizing the bioresin bulk with tissue-specific neo-deposited extracellular matrix. Importantly, printed hydrogels embedding complex channels with perfusable lumen (diameter <200 μm) were obtained, replicating anatomical 3D networks with out-of-plane branches (i.e. brain vessels) that cannot otherwise be reproduced by extrusion bioprinting. This versatile bioresin platform opens new avenues for the widespread adoption of lithographic biofabrication, and for bioprinting complex channel-laden constructs with envisioned applications in regenerative medicine and hydrogel-based organ-on-a-chip devices.
Keywords: Biofabrication and bioprinting, Lithography, Bioresin, Hydrogel, Digital light processing
Graphical abstract
1. Introduction
The automation of the in vitro production of living tissues and the generation of clinically relevant, centimeter-scale constructs remains a major hope towards the availability of implantable grafts for regenerative medicine, as well as for manufacturing advanced in vitro models for drug discovery [1].
The intricate structure of biological tissue is a result of a precise sequence of cell-driven processes occurring during tissue development, which, in a laboratory settings, to date can only be partially recapitulated within miniaturized-scale structures originated by stem cells, such as organoids [2]. Conversely, reconstructing functional biological constructs through an engineering- and design-driven approach, in which biomaterials and cell-based building blocks can be assembled in a spatially controlled fashion, remains a major challenge. In native tissues and organs, biological function is intimately linked to tissue structure and architecture, in which different extracellular matrix components and cells are organized [3]. The recent advances in biofabrication technologies, which comprise the rapidly evolving field of three-dimensional (3D) bioprinting [4], are aiding material scientists, biologists and engineers to recapitulate more closely the spatial patterning found in native tissues, and thus producing, in a laboratory settings, a new generation of cell-laden, three-dimensional constructs that can mimic salient functions of native organs [3,5].
In the past decade, most engineering and (bio)material development efforts in the field of biofabrication had been centered on extrusion-based bioprinting techniques. These involve dispensing a cell-laden suspension, termed bioink, through a nozzle which is used to build the desired object in 3D in a layer-by-layer fashion. Among the different classes of materials applied in 3D printing, bioinks are most often based on hydrogel precursors, as these provide a water-rich environment suitable to preserve cell viability during the printing process, as well as to sustain cell function post-printing, offering a 3D environment for tissue culture [6,7]. Although highly versatile, especially when aiming to print multiple materials [8], extrusion techniques generally offer a minimum resolution (≈100 μm) limited by a compromise between the nozzle diameter and the maximum shear stress that the cells can tolerate [9]. Moreover, since in most extrusion-based printers objects are built by piling dispensed hydrogel fibers on top each other layer-by-layer, resolving convoluted geometries, like woven patterns or intricate tubular networks, such as those found in several segments of the mammalian vascular system, remains a major challenge [10]. Reconstructing vascular analogues is of particular importance to ensure nutrient supply to large, centimeter-scale constructs. In this perspective, advanced biofabrication technologies hold the potential to recreate channels that mimic afferent and efferent vessels in terms of size and architecture, at a length scale that the spontaneous self-assembly of endothelial cells into micron-sized capillaries cannot otherwise reach [11].
Only recently, increasing attention has been directed towards the development of nozzle-free, light-based bioprinting techniques that hold an untapped potential to overcome the abovementioned limitations. Derived from conventional additive manufacturing techniques based on vat polymerization such as stereolithography [12], light-based bioprinting, involves the use of cell-laden, photocrosslinkable hydrogel precursor solutions, also termed bioresins, that are exposed to spatially coordinated light patterns. These patterns are most often produced by laser scanning or via digital micromirror devices (DMDs), triggering a locally controlled polymerization of the bioresin into the desired 3D object one layer at a time. By controlling the voxel size during the photo-exposure steps, high resolution, superior to those of common extrusion techniques can be achieved, typically in the range of 1–50 μm [13,14], and with a freedom of design that can easily resolve even convoluted microvascular-like networks [15]. Current limitations in light-based printing include the loss of cells together with the unreacted bioresin volume, and the inherent difficulties in printing with multiple resins in the same process, although elegant strategies combining microfluidics and digital light projection (DLP) bioprinting have also been introduced to allow for multi-material fabrication [16]. Moreover, light-based bioprinting uniquely enables the fabrication of features at even submicron-resolution, when adopting multiphoton polymerization [17]. Furthermore, recent developments have also demonstrated ultra-fast volumetric bioprinting of complex centimeter-scale 3D cell-laden constructs in less than 30 s, by tomographic light patterning [18]. Despite such promising advances, only few hydrogel-based bioresins are currently available, the vast majority of which are based on synthetic polymers, prevalently acrylate-derivatives of polyethylene glycol, which, in their native form, lack cell instructive cues [15,[19], [20], [21], [22]]. On the other hand, natural-origin polymers have limited capacity to enable bioprinting with high resolution and shape fidelity. Such hydrogel-forming materials are prevalently used at low polymer concentration in order to form structures with low stiffness suitable for optimal cell culture, but thus with limited ability to preserve the geometry imposed by the printing process. Among natural hydrogels, photo-responsive gelatin derivatives are widely studied across a range of biofabrication techniques, due to their favorable biological performance in terms of cell adhesion domains and biodegradability. Most works focused on extrusion printing techniques, in which printability and shape fidelity are primarily governed by the rheological properties of the bioinks, particularly their viscosity, the presence of a yield stress, a marked shear-thinning profile and quick shear recovery kinetics, and quantitative descriptions of these parameters have been extensively covered in the literature [[23], [24], [25]]. In such applications, the well-described thermo-sensitive behavior of gelatin is advantageous. On the contrary, bioresins for light-based printing display different rheological requirements. In fact, printability is mainly dependent on photochemical properties, which determine reactivity, resolution and shape fidelity of the printed construct [26], and low-viscosity materials (typically 0.25–10 Pa s [27]) are preferred instead of polymers that gelate around room temperature. Thus, developing a new range of bioresins that preserve the inherent bioactivity of gelatin, while permitting ease of application for lithography-based bioprinting and maximal resolution, could open new possibilities for the field of biofabrication.
This work describes a novel strategy to bioprint high-resolution living constructs featuring embedded free-form microfluidic, vessel-like channels, permitted by the development of a thermostable hydrogel-based platform for DLP bioprinting, that can be used on any DLP device. Photo-responsive ichthyic-origin gelatins, displaying low melting point and bearing acryloyl and norbornene groups, and which span a wide array of mechanical properties were developed as visible-light responsive bioresins for DLP printing. A particular attention was directed towards designing a system to enable prints with high shape fidelity microchannels, even when using hydrogels displaying very low stiffness (∼1 kPa). Such system would overcome the current limitations experience in the field of DLP (bio)printing, which is mostly reliant on stiff high polymer content materials [28], and thus can open new opportunities for material scientists, engineers and biologists to build the next generation of 3D constructs with ideal properties for cell encapsulation, tissue engineering and regenerative medicine. The DLP working curve for the low-temperature soluble gelatin-based bioresins, exposure settings and printing resolution were described as a function of crosslinking chemistry and the polymer concentration. To maximize printing resolution, an array of biocompatible food dyes were studied as photoabsorbers to modulate the spatio-selective crosslinking of the gelatin derivatives. The resulting bioresins were studied for their potential to sustain long-term functionality and differentiation capacity of bioprinted stem cells. Furthermore, the bioresins allowed the production of in-hydrogel perfusable microvascular-mimetic networks branching in the x, y and z directions. Finally, together with this superior printing resolution and freedom of design, further modification of the bioresin composition was also investigated in order to produce hydrogel-built structures with tunable bulk diffusion properties.
2. Experimental section
2.1. Macromere synthesis and hydrogel preparation
Low temperature soluble (LTS) bioresins were synthesized starting from gelatin from cold water fish skin (Sigma-Aldrich, the Netherlands). For the synthesis of gelatin methacryloyl (GelMA), an adapted version of a previously published protocol was followed [29]. Briefly, the LTS gelatin was dissolved in phosphate-buffered saline (PBS) to form a 10% w/v solution, and it was reacted with 1:0.6 methacrylic anhydride (Sigma-Aldrich, The Netherlands) at 37 °C for 1 h, to obtain an ≈90% degree of modification of the lysine residues (Supplementary Figs. S1 and S2). The quantification of the degree of modification was performed according to a previous published protocol [30], and further details are reported in the Supplementary Information. Gelatin norbornene (GelNB), able to undergo thiol-ene photo-click crosslinking, and thus enabling the fabrication of more controlled hydrogel networks when compared to chain polymerization [31], was also obtained through a synthesis protocol based on previous reports [32,33]. Gelatin (10% w/v) was dissolved in PBS and supplemented with a 20% w/v carbic anhydride (Acros Organics, Belgium). The pH of the mixture was continuously adjusted to 7.5–8.0 using 1 M NaOH, as the carbic anhydride dissolved. Once the pH stabilized, the reaction was left to run in the dark for 24 h, to obtain a final degree of substitution of ≈85% (Supplementary Figs. S1 and S3), after which it was quenched by a 1:3 dilution with PBS. For both LTS-GelMA and -GelNB, excess of the respective anhydride was removed by centrifugation, and the remaining solutions were neutralized, dialyzed against distilled water (MWcut-off = 12,000 Da), sterile-filtered, freeze-dried and stored at −20 °C until used. To prepare the different hydrogels, LTS-GelMA and -GelNB were dissolved in PBS at the desired concentration, in presence of 2 mM tris(2,2′-bipyridyl)ruthenium (II) chloride hexahydrate (Acros Organics, Belgium) and 20 mM sodium persulfate (Acros Organics, Belgium) (Ru/SPS), which acted as visible light photoinitiator able to minimize the effect of oxygen inhibition on photocrosslinking, as previously demonstrated [14,34]. In the case of step growth polymerizable LTS-GelNB, a tetra-thiol polyethylene glycol-based crosslinker (4-arm PEG-SH, Mw = 5000 Da, JenKem Technology, USA) was added to achieve a 1:1 M ratio of thiol groups to the norbornene groups from the gelatin backbone. Macromer solutions were then exposed to a visible light lamp (600 lumen, λ = 400–700 nm, I = 6.5 mW/cm2 at 450 nm and at a distance of 10 cm) for 7.5 min to crosslink into the desired gelatin-based hydrogels.
2.2. Physico-chemical characterization of the hydrogels
Gelatin hydrogel precursor solutions at different polymer concentrations were casted into custom-made polydimethylsiloxane (PDMS) molds and photocrosslinked to obtain cylindrical samples (diameter = 5 mm, height = 1 mm). Samples (n = 3) were weighed to obtain the initial wet weight (min t = 0) or lyophilized overnight first, to obtain their dry weights (mdry t = 0). These samples were then incubated in PBS at 37 °C overnight, freeze-dried and weighed (mdry). The sol fraction was then calculated via Equation (1):
(1) |
The mechanical properties of the hydrogels were measured in an unconfined, uniaxial compression test, using a dynamic mechanical analyzer (DMA, Q800, TA Instruments, USA). Cylindrical samples (n = 3) were incubated in PBS overnight, and subsequently subjected to a strain ramp (−20% strain/minute, preload 1% strain). The compression modulus was calculated from the slope of the stress-strain curve in the 10–15% strain region.
2.3. Bioresin formulations, effect of photoabsorbers and DLP working curve
The UV–vis absorption spectra of the Ru/SPS mixture and several photoabsorbers in the 300–650 nm region were obtained using a spectrophotometer. Candidate photoabsorbers were new coccine (red, Queen Fine Foods, Australia), a mixture of tartrazine and azorubine (yellow, Queen Fine Foods, Australia), and fast green (Sigma-Aldrich, the Netherlands). Dyes that attenuated but not entirely blocked light transmission in the spectral region coinciding with the absorption peak of Ru/SPS and with the main emission peak of the light source used in the DLP printer (Perfactory 3 Mini, Envisiontec, Germany) were selected for bioprinting. Next, bioresins composed of Ru/SPS, the selected photoabsorber at varying concentrations, and either LTS-GelMA or -GelNB, were loaded onto a glass slide placed on the vat of the printer, and irradiated to print disc shaped samples (diameter = 4 mm), exposed to increasing irradiation doses (n = 3 per dose). The curing depth (Cd) was obtained measuring the height of each disk using a stereomicroscope. The height of the disks, equivalent to Cd was plotted as a function of the respective irradiation energy. The DLP working curve was thus obtained as the linear relation between a given dose (expressed in logarithmic scale) and Cd. The curve is also defined by equation (2), with Dp being the light penetration depth, and Ec the critical energy to reach the gel point:
(2) |
For each bioresin formulation, Dp can thus be obtained as the slope of the working curve, and Ec is therefore obtained by solving equation (2), as previously described [14].
2.4. DLP bioprinting
2.4.1. Cell harvesting, printing and viability
Bone marrow-derived mesenchymal stromal cells (MSCs) were obtained post-mortem from the sternum of a skeletally mature equine donor (age = 5 years old), as previously described [35]. The horse was donated to science by its owner, in accordance to the ethical guidelines of the Faculty of Veterinary Medicine of Utrecht University. Isolated MSCs were cultured in expansion media, consisting of in alpha-MEM (Life Technologies, the Netherlands), supplemented with 10% FCS, 100 U/mL of penicillin, 100 μg/mL of streptomycin, 0.2 mM of L-ascorbic acid-2-phosphate and 1 ng/mL of basic fibroblast growth factor (bFGF, R&D Systems, USA). Cells were used at passage 4 to 6 for all experiments. A schematic representation of the bioresin composition is depicted in Fig. 1. For DLP bioprinting, MSCs were suspended in the bioresin formulations (supplemented at a concentration of 107 cells/mL). Constructs were printed with optimized settings based on the data derived from the working curve, using a layer height of 50 μm, with a power density of 6.5 mW/cm2 at the surface of the vat, and 10 s of exposure time per each layer. After printing, cell-laden constructs (n = 3 per condition and time point) were kept in culture in expansion media, and viability was assessed at day 1 and 7, using a live/dead assay, using 1 μg/mL of calcein AM and ethidium homodimer-1 (Life Technologies, the Netherlands). For each construct, 5 random sections were imaged using a fluorescence microscope (BX51 Olympus, the Netherlands), and the amount of living cells were manually counted using ImageJ.
2.4.2. Printing resolution and bioresin stability over time
To characterize the printing resolution, a calibration structure consisting of an array of positive (comb-like posts) and negative (hollow channels and spacing) features of decreasing size was printed. Optical micrographs of these prints (n = 3 per condition), obtained from both LTS-GelMA 10% w/v and LTS-GelNB 5% w/v were captured, and the characteristic dimensions of the positive and negative features measured with ImageJ and compared to the original computer design. Next, the stability of the bioresin upon mixing with the photoinitiators was assessed by printing disc shaped constructs (diameter = 5 mm, height = 1 mm, n = 3) after an increasing latency time. Upon addition of Ru/SPS, LTS-GelMA and LTS-GelNB were kept in the dark and photoexposed after 0, 15, 30, 45 or 60 min. The efficiency of crosslinking was estimated measuring the compressive modulus of the discs, following the procedure described in Section 2.2.
2.4.3. Long-term cell function post-printing
To assess the ability of the printed bioresin to provide a permissive environment for cell differentiation, MSC-laden (107 cells/mL) LTS-GelMA disc-shaped constructs (n = 3 per culture condition) were bioprinted, and cultured for 28 days in either i) osteogenic medium (α-Minimum Essential Medium (MEM), supplemented with 10% FCS, 100 U/mL of penicillin, 100 μg/mL of streptomycin, 0.2 mM of L-ascorbic acid-2-phosphate, 20 mM of β-glycerophosphate, 10 nM of dexamethasone); or ii) chondrogenic medium (Dulbecco's Modified Eagle Medium (DMEM), supplemented with 1% insulin-transferrin-selenous acid premix (ITS-premix, Corning), 100 U/mL of penicillin, 100 μg/mL of streptomycin, 0.2 mM of L-ascorbic acid-2-phosphate, 100 nM of dexamethasone, 10 ng/mL of human recombinant transforming growth factor β1 (TGF-β1, PeproTech, UK)); or iii) under a hypertrophic differentiation regime, consisting of 14 days of exposure to chondrogenic media, followed by 14 days of exposure to hypertrophy induction media (DMEM, 1% ITS + premix, 10−9 M of dexamethasone, 10 mM of β-glycerophosphate, 0.2 mM of L-ascorbic acid 2-phosphate, 100 U/mL of penicillin, 100 μg/mL of streptomycin, 1 nM of 3,3′,5-triiodo-L-thyronine (T3, Sigma-Aldrich, the Netherlands)) [36]. After 28 days, samples were cut into 3 parts for: histological processing, quantification of sulphated glycosaminoglycans (sGAGs) and quantification of alkaline phosphatase activity (ALP). For histological processing, the samples were fixed in neutral buffered formalin, dehydrated in a graded ethanol series, cleared with xylene and embedded in paraffin. Microtome slices (10 μm thick) were obtained, and used for immunohistochemical staining. Immunostaining for collagen type II, performed according to a previously published protocol [35], a hallmark ECM component from cartilage was used as a qualitative marker for chondrogenic differentiation, while the von Kossa staining [36] was used to detect the presence of mineralized matrix, characteristic of MSC commitment towards osteogenesis or hypertrophic chondrogenesis. For the quantitative assessment of sGAGs, harvested samples were frozen and stored at −20 °C. Next, samples were thawed and digested with papain and sGAGs measured with a dimethylmethylene blue (DMMB) assay following previously published protocols [37]. Samples for ALP activity quantification were instead freshly ground with a pestle and incubated in mammalian protein extraction reagent (MPER, Life Technologies, the Netherlands). The obtained cell lysates were used to perform a p-nitrophenyl phosphate assay (SIGMAFAST, Sigma-Aldrich, the Netherlands), as previously reported [38]. Both sGAGs and ALP quantitative data were normalized against the DNA content of the hydrogels, as determined using the Quant-iT-Picogreen-dsDNA kit (Molecular Probes, Invitrogen, USA).
2.4.4. Bioprinting of complex and perfusable vascular-like networks
A series of LTS-GelMA hydrogel-made models, embedding vascular-like channels of increasing geometrical complexity were printed and manually perfused to assess the highest resolution achievable when producing such structures, and to demonstrate the ability to generate branched channels extending into the x-y-z directions. Structures were designed in Tinkercad (Autodesk, USA) and converted to STL files to be used in the DLP printer. First, an array of straight channels with decreasing lumen diameter (1 mm–0.1 mm) and perpendicular to the direction of the light projected by the printer were built. Samples where perfused by manually pipetting a dyed aqueous solution (Queen Red food dye, Queen Fine Foods, Australia), and imaged with a stereomicroscope to identify the smallest resolvable channels. Next, several microfluidics-inspired channels were printed, including a spiraling vessel wrapping around a straight vessel. In this structure, both channels were perfused with the radiopaque contrast agent MICROFIL (Flow Tech Inc., USA), and imaged via micro-computed tomography (μCT, Quantum FX-Perkin Elmer, voltage = 90 kV, current = 200 μA, voxel size = 20 μm3, and total scanning time = 3 min). Finally, a portion of the human cerebral arterial circle (Willis’ circle), as obtained from 3D angiographic images, was scaled down and reproduced within a printed hydrogel block. Given the complex and ramified structure of this vessel network, one entry and one exit tube were drawn and connected manually in the CAD software, to ensure the formation of a single open circuit with no dead ends. Samples were perfused as described above and imaged with a stereomicroscope (Olympus SZ61, Japan).
2.4.5. DLP bioprinting of emulsion bioresins with enhanced permeability
To demonstrate the further possibility to introduce microporosity within the bioprinted hydrogel bulk, the bioresin formulation was modified to form an aqueous two-phase emulsion (ATPE) bioresin [[39], [40], [41]]. For the ATPE bioresin preparation, LTS-GelMA solution and porogen solution were dissolved in PBS separately. The pore-forming bioresin was then achieved by mixing the two solutions via pipetting, to reach the final LTS-GelMA concentration at 15% w/v and 1.6% w/v polyethylene oxide (PEO, Mw = 300 kDa, Sigma-Aldrich, USA) as a porogen. This specific GelMA concentration was chosen based on our preliminary tests, which suggested that a lower concentration did not support faithful DLP bioprinting of 3D constructs when combined with the high microporosity introduced by PEO-driven phase separation. The visible light photoinitiator system (Ru/SPS), and the new coccine photoabsorber were added to complete the bioresin formulation. Next, the pore-forming bioresin was printed with a DLP-based 3D bioprinter, which was custom-built using a visible-light projector (ViewSonic PA503W, USA). The permeability of the bioprinted constructs was assessed by, printing a cubic construct with an embedded central channel, and injecting the water-soluble red dye into the channel at the rate of 100 μL/h, using a syringe pump (New Era Pump Systems, USA). The diffusion profiles were evaluated over time for samples bioprinted with the porous LTS-GelMA and the standard LTS-GelMA without supplementation with the pore-forming PEO. An inverted fluorescent microscope (Nikon, Japan) and ImageJ were used to record and analyze the diffusion profiles.
2.5. Statistical analyses
Each experiment was performed in three replicates (n = 3). Quantitative results are reported as means ± standard deviations. Statistical analyses were performed with GraphPad Prism 6.0 (GraphPad Software, USA). Single comparisons were performed with a Student's t-test. Multiple comparisons between the experimental groups were performed using a one-way ANOVA, with a Bonferroni post-hoc test. Assumption of normality was checked with a Shapiro-Wilk test. When samples with not normal distribution were found, non-parametric tests were used (Mann-Whitney and Kruskal-Wallis tests). Values of p < 0.05 were considered statistically significant.
3. Results and discussion
3.1. Targeting hydrogel physico-mechanical properties for bioprinting applications
A family of gelatin-based hydrogels with varying polymer content were synthesized and characterized to produce bioresins able to display thermal stability in solution prior to crosslinking (Supplementary Fig. S4), to cover a broad range of mechanical properties suitable for cell encapsulation. First, all samples demonstrated a relatively low sol fraction (<40%, Fig. 2A), with no significant differences observed between LTS-GelMA and LTS-GelNB of various weight percentages. This result indicates that the crosslinking efficiency was similar for LTS-GelMA and LTS-GelNB hydrogels, despite them undergoing fundamentally different crosslinking mechanisms, namely chain-growth or step-growth reactions, respectively. However, only for the 5% w/v LTS-GelMA samples, the formed hydrogels demonstrated poor shape retention even upon gentle handling. Moreover, mechanical testing showed an obvious trend where increasing macromer concentration led to hydrogels of higher compressive moduli for both LTS-GelMA and LTS-GelNB (Supplementary Fig. S5). It was further observed that LTS-GelNB hydrogels showed higher tunability, where hydrogels over a wider range of compressive modulus (∼40-fold increase, 1.38 ± 0.05–55.63 ± 1.51 kPa, Fig. 2B) could be achieved by simply varying the macromer concentration from 5 to 15% w/v. In contrast, increasing LTS-GelMA from 5 to 15% w/v only resulted in an approximately 7-fold increase (0.99 ± 0.19–6.81 ± 1.20 kPa, Fig. 2B) in compressive stiffness. This evident difference between GelMA and GelNB even at comparable macromer concentration and sol fraction values can be explained by the fact that, in the LTS-GelNB samples, a non-zero length crosslinker needs to be incorporated in the forming hydrogel network. In this study, we selected as crosslinker 4-arm PEG-SH, with a Mw of 5000 Da, which is directly covalently bound in the hydrogel and thus likely contribute to the mechanical properties of the system, leading to the enhanced compressive modulus.
Interestingly, the moduli observed for LTS-GelMA appeared to be lower than previously reported values for porcine skin-derived GelMA, a difference likely due to the lower content of hydroxyproline present in fish-derived gelatin, which in turn results in triple helices with lower melting point and mechanical stability [42,43].
A paramount feature of cell-laden hydrogels for engineering connective tissues, in which extracellular matrix (ECM) components are predominant (such is the case for bone or cartilage), is their ability to permit colonization and integration of neo-synthesized ECM macromolecules throughout the whole volume of the hydrogel. Previous work extensively highlighted the impact of tuning hydrogel stiffness in order to achieve successful cell differentiation [44], and several published reports on cartilage tissue engineering demonstrated how hydrogels with a higher degree of crosslinking, resulted in reduced cartilage matrix deposition, mainly confined to the pericellular environment [45]. Although such a result is dependent on several physico-chemical aspects of the hydrogel network including the available free space, mesh size, diffusivity, mechanical properties and charge distribution, stiffness measurements generally offer a good indication for hydrogel performance. For example, previous work demonstrated an clear difference for GelMA-based gels with compressive stiffness below ∼50 kPa [46] resulting in a homogenous distribution of collagenous and glycosaminoglycan-rich matrix, and similar results in gels with a stiffness <5 kPa [47] for bone-like matrix distribution from encapsulated stem cells. As such, in this work, after excluding the 5% w/v GelMA group due to its lack of structural stability, we selected the bioresin formulations LTS-GelMA 10 and 15% and LTS-GelNB at 5 and 10% w/v for further characterizations, which yielded hydrogels with a stiffness within the 1–30 kPa range.
3.2. Constructing the working curve for LTS-GelMA and LTS-GelNB bioresin to enable high-resolution printing
In the design of a resin formulation for DLP printing, the selection of a photoinitiator compatible with the light source of the printer, and of a photoabsorber compound are crucial. In particular, photoabsorbers are intended to limit light penetration beyond the intended crosslinked layer thickness, while not significantly impairing the photocrosslinking reaction [48,49]. The light source of the DLP printer used in this study has a main, narrow emission peak at 405 nm, and a secondary peak at 515 nm. This overlaps with the broader absorbance peak of the Ru component of the photoinitiators used in this study, which absorbs over the visible light range (400–500 nm, with a tail extending beyond 500 nm) with a maximum at 450 nm (Fig. 3A). Under such blue light stimulation, Ru reacts with SPS to generate free radicals that can be used to trigger both addition polymerization as well as thiol-ene step-growth polymerization [31,37]. In this study, we compared the absorption spectra of three different compounds as candidate biocompatible photoabsorbers, that are commonly used as dyes in the food industry: new coccine, tartrazine and fast green (Fig. 3B). It was observed that 1% fast green, with a primary absorption peak at about 600 nm had limited capacity to attenuate light at 405 nm, and thus modulate light penetration depth into the bioresin. On the other hand, tartrazine has a prominent absorbance peak at 405 nm, which is in the same, desirable absorbance range of Ru, but offers no overlap with the secondary emission peak of the DLP projector, especially if tested at low concentrations needed to not completely block light penetration into the bioresin. This may still induce unwanted radical generation from the photoinitiator system, thus finally affecting printing resolution. Based on the absorbance spectra, we then identified that new coccine is the most suitable photoabsorber as a key component for our bioresin, as it shows a more pronounced absorbance between 450 and 550 nm, and a mild attenuation capacity at 405 nm, which can be readily modulated in a concentration dependent manner (Fig. 3C). Therefore, we systematically assessed the light curing performance of different new coccine/pre-polymer combinations, and thus drew the working curve for both LTS-GelMA and -GelNB (Fig. 3D – G). While all the hydrogels formulation can technically be printable as long as they can undergo photopolymerization, the expected and achievable printing resolution depends on the response of the material to the supplied light dose. Thus, the working curve determines the range of possible resolutions that can be obtained with a given material. For all the formulations tested, there was a clear trend where increasing new coccine concentration within the bioresin reduced the slope of the working curve. Cure depths (Cd) of ∼50 μm could be achieved for both LTS-GelMA and LTS-GelNB by using higher new coccine concentration (0.07% w/v), indicative of higher print resolution. It should also be noted that attempts to print structures with a new coccine concentration higher than 0.07% w/v led to no crosslinking at any of the tested light intensities (data not shown). Consistently, increasing the concentration of new coccine in either 10% or 15% w/v LTS-GelMA led to a decrease in light penetration depth (Dp) (Fig. 3H), a parameter intrinsic to each resin formulation. Interestingly, this effect was not significantly observed in LTS-GelNB (Fig. 3H), suggesting that the thiol-ene crosslinking mechanism, well-known for its faster kinetics and lower activation threshold compared to acryloyl-based addition polymerization [50], paired with the high reactivity of the Ru-based initiator, made it more difficult to detect subtle changes in the Dp value. In contrast, a higher critical energy (Ec) is required for gel formation when a higher concentration of new coccine was used in both LTS-GelMA or LTS-GelNB bioresins (Fig. 3I), irrespective of the macromer concentration.
3.3. Cytocompatibility assessment and DLP printing of LTS-GelMA or LTS-GelNB hydrogel constructs
To ensure the applicability of these bioresins in the fields of bioprinting and tissue engineering, we further encapsulated bone marrow-derived MSCs into LTS-GelMA or LTS-GelNB to perform cytocompatibility assays. For both LTS-GelMA and LTS-GelNB, cells survived the crosslinking process, with excellent cell viability (green cells, Fig. 4A) at the two time points (day 1 and day 7) evaluated. More specifically, at day 1, the samples displayed a percentage of viable cells ranging from 68.02 ± 8.60% for 5% w/v GelNB to 84.07 ± 6.27% for the 15% w/v GelMA, while at day 7, values ranged from 80.74 ± 3.06% (5% w/v GelNB) to 91.10 ± 4.51% (15% w/v GelMA) (Fig. 4B). Interestingly, a significant increase in cell viability from day 1 to day 7 was only observed for 10% w/v LTS-GelMA (73.99 ± 3.27% at day 1, and 85.46 ± 4.45% at day 7, p < 0.05). Thus, no noticeable cytotoxic effect could be detected, in line with previous reports for photo-encapsulation of MSCs in porcine-derived GelMA and GelNB [32], underlining how both LTS-GelMA and LTS-GelNB are cytocompatible bioresins suitable for biofabrication of cell-laden constructs.
As both 10% w/v LTS-GelMA and 5% w/v LTS-GelNB showed comparable compressive moduli between 1 and 2 kPa, penetration depth and critical energy, these two bioresin formulations were further selected to perform more complex prints via DLP. The comparable mechanical properties were also confirmed in terms of shear modulus, as shown through photorheological characterization. The LTS-GelNB resin exhibited faster gelation kinetics, reaching a storage modulus plateau earlier upon light exposure, when compared to LTS-GelMA. (approximately 4 min for GelNB and 7 min for GelMA, Supplementary Fig. S2). This faster gelation kinetics profile is comparable with what was previously reported for thiol-norbornene systems [51]. Both hydrogel formulations also showed to be stable upon overnight swelling (Supplementary Fig. S7), and to be susceptible to enzymatic degradation, as tested upon exposure to collagenase (Supplementary Fig. S8), the latter being a necessary requirement for matrix remodelling in tissue engineering applications. However, given the low mechanical properties, it was uncertain whether, even with such soft materials it was possible to resolve minute architectural features with good shape fidelity upon (bio)printing. Hydrogels (including gelatin-derived) displaying compressive moduli as low as ∼1 kPa have been previously processed via DLP printing, to generate simple structures, such as microgels as injectable carriers for cell delivery [52], an application for which shape retention in convoluted geometries is not necessarily needed. Conversely, structural elements, hydrogel-based microfluidic chips, and perfusable networks, have been produced primarily with hydrogels displaying compressive stiffness in the range of tens to hundreds of kPa [15,21,[53], [54], [55]].
We firstly evaluated the maximum resolution that could be achieved with the two selected bioresin formulations by printing a simple comb structure. The structure was designed to contain both protrusions and hollow channels with decreasing thickness to evaluate the possibility to form positive and negative features within the hydrogel constructs using DLP printing (Fig. 5). In all printed samples, voxelated surface patterns can be easily recognized, which are a direct result of the light projected from the pixels composing the micromirror device. Solid comb structures of good spatial definition were successfully printed for both LTS-GelMA or LTS-GelNB (Fig. 5A–D). However, a higher resolution was displayed with LTS-GelMA. With this gel, the smallest positive feature obtained was 65 ± 14 μm as opposed to 76 ± 18 μm achieved with LTS-GelNB, although this difference was not statistically significant (Table 1, Fig. 5B–E, Supplementary Fig. S9). It should be noted that while the resin and printer described in this study allow printing of pixel-wide positive features, given the low mechanical properties of these bioresins, such thin structures are more likely to be damaged during handling of the prints or during the necessary washing steps. Additionally, LTS-GelMA also resulted in significantly smaller negative features (open channel) of 64 ± 7 μm in comparison to 95 ± 21 μm achieved with LTS-GelNB, when aiming to obtain a 100 μm channel, indicative of a slightly higher overcrosslinking of the surrounding borders of the cavity, (Table 1, Supplementary Fig. S10), while attempts to resolve channels with theoretical designed sizes between 12.5 and 50 μm resulted in partially clogged structures, likely due to the diffusion of reactive species during crosslinking or undesired light scattering (Fig. 5C–F). These results further expand the potential to resolve minute structures when using soft natural origin hydrogels, since to date, single pixel features have been achieved prevalently with stiff, synthetic materials (i.e., PVA-MA [14]). Such stiff resins have also been traditionally needed for resolving open channels with diameters <100–200 μm (PEGDA [[56], [57], [58]]). Achieving these intricate features with simple gelatin-based materials, however, has only been possible by developing custom, specialized DLP printers that are engineered to improve resolution by using optics to miniaturize the print itself, thus compromising on the overall size of the achievable objects [59]. In addition, given that direct comparisons between published literature utilizing different DLP and SLA systems for hydrogel printing are difficult due to the lack of homogenous reporting of key printing parameters and print outputs, we are therefore including in the Supplementary Information a table summarizing the main settings and printing results observed in our study and in other relevant, recent references from the literature (Supplementary Table ST1).
Table 1.
Feature | Designed size | LTS-GelMA | LTS-GelNB |
---|---|---|---|
Smallest post (positive feature) | 50 μm | 65 ± 14 μm | 76 ± 18 μm |
Smallest open gap∗ (negative feature) | 100 μm | 64 ± 7 μm | 95 ± 21 μm |
Next, as a preliminary step for 3D printing of larger structures extending in the z-direction, the stability of both LTS-GelMA or LTS-GelNB bioresin was further evaluated. The LTS-GelMA or LTS-GelNB macromer solution were firstly mixed with Ru/SPS and the photoabsorber, then their ability to be printed were tested at every 15 min over a time interval up to 1 h. It was observed that LTS-GelMA bioresin remained stable over the 1-h window, where all the printed gels yielded similar compressive moduli (Fig. 6). In contrast, the LTS-GelNB bioresin had a limited print window over time, where a significant reduction in compressive modulus was observed after 30 min of bioresin preparation, where no gels were formed after 45 min of mixing the photoinitiator and photoabsorber into the LTS-GelNB macromer solution. Previous work suggested that Ru/SPS could mediate thiol-persulfate redox reactions even in the absence of light and in a time-dependent fashion [60]. This was likely the reason for the loss of reactivity of the LTS-GelNB resin, due to an early and undesired conversion of norbornene groups. Consequently, despite the proven possibility to print thin structures with resolution in the range of 50–100 μm, LTS-GelNB does not appear to have sufficient stability necessary to DLP fabricate structures that require more than 30 min to be printed, at least in the formulations reported in this work. With the settings and DLP printer used in this study, 30 min translates into approximately 2 mm in height. This could be sufficient in several tissue engineering applications, for instance in many organ-on-a-chip applications or when thin regenerative hydrogels need to be fabricated [61].On the other hand, larger 3D structures laden with perfusable cylindrical samples could be produced using LTS-GelMA at 10% w/v (Supplementary Fig. S11), which was thus selected for further investigation in this study.
3.4. DLP-bioprinted LTS-GelMA constructs preserve long-term cell functionality
Having identified a preferred bioresin formulation from the initial library, we then proceeded to evaluate the long-term survival and functionality of MSCs in DLP-bioprinted LTS-GelMA hydrogel constructs, in particular in the context of bone and cartilage tissue engineering. In that area of research, MSCs have been extensively used for their capacity to directly deposit bone-like and cartilage-like matrix when differentiated into osteoblastic or chondrogenic lineages, respectively [62,63]. In addition, some bone tissue engineering strategies that aim to mimic bone formation paths typical of embryonic development rely on the initial formation of a hypertrophic cartilage template, which can later be remodeled into bone upon implantation in vivo [64]. In the bioprinted hydrogel samples, it was observed that the encapsulated MSCs were able to retain their multi-lineage differentiation capability when exposed to media derived from chondrogenic, hypertrophic and osteogenic differentiation protocols. This was evidenced by positive collagen II staining when cultured in chondrogenic or hypertrophic media, and positive von Kossa staining when cultured in hypertrophic or osteogenic media (Fig. 7A). Moreover, ECM deposition appeared diffused throughout the whole hydrogel matrix. Similarly, biochemical analysis provided a quantitative assessment of the capacity of the bioprinted MSCs to secrete tissue-specific biomarkers as a function of the applied differentiation protocol, with high GAG and low ALP synthesis in chondrogenic media (respectively 6.00 ± 1.47 ng/ngDNA and ∼2.85 ·10−5 U/ngDNA), as opposed to those found for the osteogenic media (respectively 0.32 ± 0.25 ng/ngDNA and ∼1.26 ·10−3 U/ngDNA) (Fig. 7B and C). Overall, the hydrogels provided a permissive environment for MSC differentiation and neo-matrix deposition, further suggesting the biocompatibility of the used bioresin components and of the visible-light-induced DLP printing and photocrosslinking steps.
3.5. DLP-printing of complex, channel-laden structures using LTS-GelMA bioresins
Light-based printing technologies have increasingly drawn attention for their unique ability to reproduce convoluted geometries that are not possible to resolve when using conventional extrusion bioprinting techniques. Notable examples include triply periodic minimal surface (TPMS) structures (including gyroids) [14], and the shaping of vessel and airway-mimetic channel networks within hydrogel blocks, that can also be used to provide nutrients to encapsulated cells [15]. We further examined the feasibility of using the 10% w/v LTS-GelMA bioresin to fabricate complex 3D structures laden with vessel-like channels with increasing architectural complexity (Fig. 8), leveraging its ability to resolve patent channels with a lumen of ∼200 μm, even when printed in the direction perpendicular to the direction of light irradiation (Supplementary Fig. S12). Firstly, a hydrogel block with an embedded 3-way microfluidic geometry was successfully printed within a bulk hydrogel replicating the original CAD-design (Fig. 8A). Other complex designs, including a structure with two open channels consisting of a hollow spiral channel wrapped around a horizontal channel were also successfully printed within a bulk LTS-GelMA hydrogel (Fig. 8B), further showcasing the potential of the bioresin. Injection of radiopaque contrast agents provided a visual demonstration of the perfusability of these 3D channels (Supplementary Fig. S13). Given the freedom of design provided by DLP bioprinting, an array of positive features were successfully printed consisting of peaks and valleys mimicking the crypt-villi composition of the intestinal tract, with a branched network of open channels placed underneath (Fig. 8C). High resolution features such as a branched microfluidic network with varying channel diameters (Fig. 8D) and anatomical replica of blood vessels within a region of the human Circle of Willis based on 3D angiographic data (Fig. 8E, Supplementary Fig. S9), were also successfully printed. The possibility to perfuse these structures was proven via the infusion of a colored dye solution, and the smallest tubular feature within the complex Willis vessel network was measured to be 183 ± 25 μm. Overall, the possibility to generate such high resolution, convoluted structures via vat polymerization printing has not been achieved with other gels with low compressive properties, not even when utilizing other types of low viscosity gelatins obtained from the partial degradation of the polymer backbone [65]. It should be noted that, in the proof-of-concept prints reported in our study, perfusion was demonstrated via manual injection, recent reports in the literature highlight elegant strategies for enabling the connection of hydrogel-based constructs to fluidic tubing and circuits, which could be applied to automate fluid flow [66]. To date complex and branched omnidirectional network of channels have been reported via lithographic printing mainly in stiff synthetic hydrogel, most commonly PEGDA [15] or GelMA and PEGDA blends [28,67], which result in dense networks that limit the range of applications to tissues or models in which cell migration is not needed [68]. Gelatin-only hydrogels, although widely investigated in the field of biofabrication, have been mainly processed to form channels with planar geometries [16,59,[69], [70], [71]]. Out-of-plane branches, highly relevant when addressing the complexity of vascular systems, have been obtained via extrusion printing thanks to the use of sacrificial materials, suspended printing and coaxial nozzles [10,[72], [73], [74]], leveraging on the ability of support materials and viscosity enhancers to preserve the shape of the printed channels. However since prints need to account for the presence of a nozzle, channels forming 3D loops are more difficult to generate with such approaches, and stereolithographic techniques display a superior freedom of design in these cases, as also shown in this present work. Taken together, our results so far showed that unprecedented complex structures can be DLP-printed using the LTS-GelMA bioresin developed in this study. Such anatomical structures could potentially find application in the vascularization of engineered tissues and in organ-on-a-chip devices, for instance in set-ups involving the study of the role of physiological and abnormal blood vessel geometry in vascular diseases, such as thrombotic events [75].
3.6. DLP printing of pore-forming LTS-GelMA bioresin
As a final step for the characterization of the LTS-GelMA bioresin, we explored the possibility to modulate the permeability of the hydrogel via the introduction of microporosity within the bioprinted structures. Besides working with hydrogels displaying relatively low polymer content and compressive stiffness, in order to enhance cell-material interactions, as well as to promote nutrient transport across a bioprinted construct, a unique ATPE strategy has been recently introduced [[39], [40], [41]]. Here, we utilized PEO as a porogen to emulsify the LTS-GelMA bioresin. The formation of PEO droplets dispersed in the LTS-GelMA phase could be readily observed via microscopy, and yielded droplets with an average diameter measuring 71.89 ± 17.2 μm (Fig. 9A and B), similar to our previous reports where porcine GelMA was used. With this emulsified bioresin, DLP bioprinting was subsequently performed to reproduce the logos of Utrecht University, University of Otago and Harvard Medical School (Fig. 9C). Additionally, to investigate if volumetric structures could also be fabricated, a 3D cubic hydrogel (10-mm length by 6-mm width by 5.6-mm height) was printed featuring a hollow channel of 1 mm in diameter in the center (Fig. 9D). When a water-soluble dye was infused in this channel, the pore-forming bioresins demonstrated a dramatic increase (∼3-fold) in the diffusion rate of the dye throughout the whole hydrogel cube, when compared to prints obtained from the standard, unmodified bioresin (Fig. 9E and F). Thus, the possibility to apply this versatile modification to the LTS gelatin bioresin extends the possibilities to modulate the mechanical performance of the resulting hydrogels, and could potentially be further investigated as an approach in the future to promote cell proliferation and colonization of the bioprinted hydrogel structure, as suggested in previous studies involving other biofabrication technologies [39].
4. Conclusions
In this study, a novel, visible light responsive gelatin-based bioresin for DLP, which is characterized by its thermal stability in solution at room temperature was developed. These unique thermal properties enable the printing of gelatin on virtually any DLP printer, even in absence of temperature controlling modules. As these are usually not available in most commercially available devices, this offers a generalizable and ready-to-use bioresin formulation. Bioresins based on methacryloyl addition polymerization and thiol-ene photocrosslinking mechanisms both displayed the ability to sustain cell viability upon printing and to resolve and print features in the range of 50 μm, even when utilizing prepolymer mixtures yielding hydrogels with low compressive stiffness in the range of 1–2 kPa. However, only LTS-GelMA demonstrated sufficient stability over longer printing times, necessary to fabricate larger constructs. Importantly, such optimized LTS-GelMA bioresins permitted the 3D printing of free-form vessel-like and microfluidic-inspired channel networks, enabling to resolve perfusable open channels smaller than 200 μm displaying any intricated geometry. In addition, these bioresins are compatible with recently developed strategies to introduce microporosity into the bulk of the hydrogel with the aim to further improve nutrient exchange within a printed gel structure. Combined with the demonstrated ability to sustain over a month of culture the multilineage differentiation ability of bioprinted stem cells, these new bioresins can open new possibilities for hydrogel-based organ-on-a-chip devices, advanced in vitro models for disease modelling and drug screening, and for the development of vascularized tissue engineering constructs.
Credit author statement
Conceptualization: R.L. (Riccardo Levato), K.L. (Khoon Lim), Tim Woodfield (T.W.), Jos Malda (J.M.); Investigation: R.L, K.L, W.L. (Wanlu Li), M.W. (Mian Wang), A.U.A (Ane Urigoitia Asua), L.B.P. (Laura Blanco Peña), Marc Falandt (M.F.), Paulina Nuñez Bernal (P.B.N.); Formal analysis: R.L., K.L., A.U.A. L.B.P., D.G. (Debby Gawlitta), Y.S.Z. (Yu Shrike Zhang). Resources: R.L., J.M.; Visualization: R.L.; Writing – original draft preparation: R.L, K.L.; Writing – review & editing: all co-authors. Project coordination: R.L., K.L., J.M., T.W. Funding acquisition: R.L., J.M. All authors have read and agreed to the published version of the manuscript.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
This project received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. 949806, VOLUME-BIO). R.L and J.M acknowledge the funding from the ReumaNederland (LLP-12, LLP22, and 19-1-207 MINIJOINT), the Gravitation Program “Materials Driven Regeneration”, funded by the Netherlands Organization for Scientific Research (024.003.013), and the osteochondral defect collaborative research program supported by the AO Foundation (Davos, Switzerland). Y.S.Z. acknowledges the support by the National Science Foundation (NSF-CBET-EBMS-1936105) and the Brigham Research Institute. K.S.L. acknowledges funding by New Zealand Health Research Council (Emerging Researcher First Grant – 15/483, Sir Charles Hercus Health Research Fellowship – 19/135) and Royal Society of New Zealand (Marsden Fast Start – MFP-UOO1826). T.W. acknowledges the Royal Society Te Apārangi Rutherford Discovery Fellowship (RDF-UOO1204), the Medical Technologies Centre of Research Excellence (MedTech CoRE), and the Ministry for Business, Innovation & Employment (UOOX1409).
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.mtbio.2021.100162.
Contributor Information
Riccardo Levato, Email: r.levato@uu.nl.
Jos Malda, Email: j.malda@umcutrecht.nl.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
References
- 1.Park J., Wetzel I., Dréau D., Cho H. 3D miniaturization of human organs for drug discovery. Adv. Healthc. Mater. 2018;7:1–26. doi: 10.1002/adhm.201700551. [DOI] [PubMed] [Google Scholar]
- 2.Clevers H. Modeling development and disease with organoids. Cell. 2016;165:1586–1597. doi: 10.1016/j.cell.2016.05.082. [DOI] [PubMed] [Google Scholar]
- 3.Levato R., Jungst T., Scheuring R.G., Blunk T., Groll J., Malda J. From shape to function: the next step in bioprinting. Adv. Mater. 2020 doi: 10.1002/adma.201906423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Groll J., Boland T., Blunk T., Burdick J.A., Cho D.-W.W., Dalton P.D., Derby B., Forgacs G., Li Q., Mironov V.A., Moroni L., Nakamura M., Shu W., Takeuchi S., Vozzi G., Woodfield T.B.F.F., Xu T., Yoo J.J., Malda J. Biofabrication: reappraising the definition of an evolving field. Biofabrication. 2016;8 doi: 10.1088/1758-5090/8/1/013001. [DOI] [PubMed] [Google Scholar]
- 5.Daly A.C., Prendergast M.E., Hughes A.J., Burdick J.A. Bioprinting for the biologist. Cell. 2021;184:18–32. doi: 10.1016/j.cell.2020.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lee J.M., Yeong W.Y. Design and printing strategies in 3D bioprinting of cell-hydrogels: a review. Adv. Healthc. Mater. 2016;5:2856–2865. doi: 10.1002/adhm.201600435. [DOI] [PubMed] [Google Scholar]
- 7.Malda J., Visser J., Melchels F.P., Jüngst T., Hennink W.E., Dhert W.J.A., Groll J., Hutmacher D.W. 25th anniversary article: engineering hydrogels for biofabrication. Adv. Mater. 2013;25:5011–5028. doi: 10.1002/adma.201302042. [DOI] [PubMed] [Google Scholar]
- 8.Kang D., Ahn G., Kim D., Kang H.W., Yun S., Yun W.S., Shim J.H., Jin S. Pre-set extrusion bioprinting for multiscale heterogeneous tissue structure fabrication. Biofabrication. 2018;10 doi: 10.1088/1758-5090/aac70b. [DOI] [PubMed] [Google Scholar]
- 9.Chimene D., Lennox K.K., Kaunas R.R., Gaharwar A.K. Advanced bioinks for 3D printing: a materials science perspective. Ann. Biomed. Eng. 2016;44:2090–2102. doi: 10.1007/s10439-016-1638-y. [DOI] [PubMed] [Google Scholar]
- 10.Song K.H., Highley C.B., Rouff A., Burdick J.A. Complex 3D-printed microchannels within cell-degradable hydrogels. Adv. Funct. Mater. 2018;28 doi: 10.1002/adfm.201801331. [DOI] [Google Scholar]
- 11.Miri A.K., Khalilpour A., Cecen B., Maharjan S., Shin S.R., Khademhosseini A. Biomaterials; 2019. Multiscale Bioprinting of Vascularized Models. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lee M., Rizzo R., Surman F., Zenobi-Wong M. Guiding lights: tissue bioprinting using photoactivated materials. Chem. Rev. 2020;120:10950–11027. doi: 10.1021/acs.chemrev.0c00077. [DOI] [PubMed] [Google Scholar]
- 13.Raman R., Bhaduri B., Mir M., Shkumatov A., Lee M.K., Popescu G., Kong H., Bashir R. High-resolution projection microstereolithography for patterning of neovasculature. Adv. Healthc. Mater. 2016;5:610–619. doi: 10.1002/adhm.201500721. [DOI] [PubMed] [Google Scholar]
- 14.Lim K.S., Levato R., Costa P.F., Castilho M.D., Alcala-Orozco C.R., Van Dorenmalen K.M.A., Melchels F.P.W., Gawlitta D., Hooper G.J., Malda J., Woodfield T.B.F. Bio-resin for high resolution lithography-based biofabrication of complex cell-laden constructs. Biofabrication. 2018;10 doi: 10.1088/1758-5090/aac00c. [DOI] [PubMed] [Google Scholar]
- 15.Grigoryan B., Paulsen S., Corbett D., Sazer D., Fortin C.L., Zaita A., Greenfield P., Calafat N., Gounley J., Ta A., Johansson F., Randles A., Rosenkrantz J.J., Louis-Rosenberg J., Galie P., Stevens K., Miller J. Multivascular networks and functional intravascular topologies within biocompatible hydrogels. Science. 2019;364:458–464. doi: 10.1126/science.aav9750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Miri A.K., Nieto D., Iglesias L., Goodarzi Hosseinabadi H., Maharjan S., Ruiz-Esparza G.U., Khoshakhlagh P., Manbachi A., Dokmeci M.R., Chen S., Shin S.R., Zhang Y.S., Khademhosseini A. Microfluidics-enabled multimaterial maskless stereolithographic bioprinting. Adv. Mater. 2018;30 doi: 10.1002/adma.201800242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ovsianikov A., Mühleder S., Torgersen J., Li Z., Qin X.H., Van Vlierberghe S., Dubruel P., Holnthoner W., Redl H., Liska R., Stampfl J. Laser photofabrication of cell-containing hydrogel constructs. Langmuir. 2014;30:3787–3794. doi: 10.1021/la402346z. [DOI] [PubMed] [Google Scholar]
- 18.Bernal P.N., Delrot P., Loterie D., Li Y., Malda J., Moser C., Levato R. Volumetric bioprinting of complex living-tissue constructs within seconds. Adv. Mater. 2019;1904209:1904209. doi: 10.1002/adma.201904209. [DOI] [PubMed] [Google Scholar]
- 19.Sharifi S., Blanquer S.B.G., Van Kooten T.G., Grijpma D.W. Biodegradable nanocomposite hydrogel structures with enhanced mechanical properties prepared by photo-crosslinking solutions of poly(trimethylene carbonate)-poly(ethylene glycol)-poly(trimethylene carbonate) macromonomers and nanoclay particles. Acta Biomater. 2012;8:4233–4243. doi: 10.1016/j.actbio.2012.09.014. [DOI] [PubMed] [Google Scholar]
- 20.Wang Z., Abdulla R., Parker B., Samanipour R., Ghosh S., Kim K. A simple and high-resolution stereolithography-based 3D bioprinting system using visible light crosslinkable bioinks. Biofabrication. 2015;7:1–29. doi: 10.1088/1758-5090/7/4/045009. [DOI] [PubMed] [Google Scholar]
- 21.Kuo A.P., Bhattacharjee N., Lee Y.S., Castro K., Kim Y.T., Folch A. High-precision stereolithography of biomicrofluidic devices. Adv. Mater. Technol. 2019;4:1–11. doi: 10.1002/admt.201800395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Neiman J.A.S., Raman R., Chan V., Rhoads M.G., Raredon M.S.B., Velazquez J.J., Dyer R.L., Bashir R., Hammond P.T., Griffith L.G. Photopatterning of hydrogel scaffolds coupled to filter materials using stereolithography for perfused 3D culture of hepatocytes. Biotechnol. Bioeng. 2015 doi: 10.1002/bit.25494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Schwab A., Levato R., D'Este M., Piluso S., Eglin D., Malda J. Printability and shape fidelity of bioinks in 3D bioprinting. Chem. Rev. 2020;120:11028–11055. doi: 10.1021/acs.chemrev.0c00084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ribeiro A., Blokzijl M.M., Levato R., Visser C.W., Castilho M., Hennink W.E., Vermonden T., Malda J. Assessing bioink shape fidelity to aid material development in 3D bioprinting. Biofabrication. 2017;10 doi: 10.1088/1758-5090/aa90e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Paxton N., Smolan W., Böck T., Melchels F., Groll J., Jungst T. Proposal to assess printability of bioinks for extrusion-based bioprinting and evaluation of rheological properties governing bioprintability. Biofabrication. 2017;9 doi: 10.1088/1758-5090/aa8dd8. [DOI] [PubMed] [Google Scholar]
- 26.Lim K.S., Galarraga J.H., Cui X., Lindberg G.C.J., Burdick J.A., Woodfield T.B.F. Fundamentals and applications of photo-cross-linking in bioprinting. Chem. Rev. 2020;120:10662–10694. doi: 10.1021/acs.chemrev.9b00812. [DOI] [PubMed] [Google Scholar]
- 27.Ng W.L., Lee J.M., Zhou M., Chen Y.W., Lee K.X.A., Yeong W.Y., Shen Y.F. Biofabrication; 2020. Vat Polymerization-Based Bioprinting - Process, Materials, Applications and Regulatory Challenges. [DOI] [PubMed] [Google Scholar]
- 28.Anandakrishnan N., Ye H., Guo Z., Chen Z., Mentkowski K.I., Lang J.K., Rajabian N., Andreadis S.T., Ma Z., Spernyak J.A., Lovell J.F., Wang D., Xia J., Zhou C., Zhao R. Fast stereolithography printing of large-scale biocompatible hydrogel models. Adv. Healthc. Mater. 2021 doi: 10.1002/adhm.202002103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Mouser V.H.M., Levato R., Mensinga A., Dhert W.J.A., Gawlitta D., Malda J. Bio-ink development for three-dimensional bioprinting of hetero-cellular cartilage constructs. Connect. Tissue Res. 2020;61 doi: 10.1080/03008207.2018.1553960. [DOI] [PubMed] [Google Scholar]
- 30.Zhu M., Wang Y., Ferracci G., Zheng J., Cho N.J., Lee B.H. Gelatin methacryloyl and its hydrogels with an exceptional degree of controllability and batch-to-batch consistency. Sci. Rep. 2019 doi: 10.1038/s41598-019-42186-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bertlein S., Brown G., Lim K.S., Jungst T., Boeck T., Blunk T., Tessmar J., Hooper G.J., Woodfield T.B.F., Groll J. Thiol–ene clickable gelatin: a platform bioink for multiple 3D biofabrication technologies. Adv. Mater. 2017;29 doi: 10.1002/adma.201703404. [DOI] [PubMed] [Google Scholar]
- 32.Mũnoz Z., Shih H., Lin C.C. Gelatin hydrogels formed by orthogonal thiol-norbornene photochemistry for cell encapsulation. Biomater. Sci. 2014;2:1063–1072. doi: 10.1039/c4bm00070f. [DOI] [PubMed] [Google Scholar]
- 33.Castilho M., Levato R., Bernal P.N., de Ruijter M., Sheng C.Y., van Duijn J., Piluso S., Ito K., Malda J. Biomacromolecules; 2021. Hydrogel-Based Bioinks for Cell Electrowriting of Well-Organized Living Structures with Micrometer-Scale Resolution. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lim K.S., Schon B.S., Mekhileri N.V., Brown G.C.J., Chia C.M., Prabakar S., Hooper G.J., Woodfield T.B.F. New visible-light photoinitiating system for improved print fidelity in gelatin-based bioinks. ACS Biomater. Sci. Eng. 2016;2:1752–1762. doi: 10.1021/acsbiomaterials.6b00149. [DOI] [PubMed] [Google Scholar]
- 35.Levato R., Webb W.R., Otto I.A., Mensinga A., Zhang Y., van Rijen M., van Weeren R., Khan I.M., Malda J. The bio in the ink: cartilage regeneration with bioprintable hydrogels and articular cartilage-derived progenitor cells. Acta Biomater. 2017;61:41–53. doi: 10.1016/j.actbio.2017.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Gawlitta D., Van Rijen M.H.P., Schrijver E.J.M., Alblas J., Dhert W.J.A. Tissue Eng. - Part A; 2012. Hypoxia Impedes Hypertrophic Chondrogenesis of Human Multipotent Stromal Cells. [DOI] [PubMed] [Google Scholar]
- 37.Lim K.S., Abinzano F., Bernal P.N., Albillos Sanchez A., Atienza-Roca P., Otto I.A., Peiffer Q.C., Matsusaki M., Woodfield T.B.F., Malda J., Levato R. One-step photoactivation of a dual-functionalized bioink as cell carrier and cartilage-binding glue for chondral regeneration. Adv. Healthc. Mater. 2020;9 doi: 10.1002/adhm.201901792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Diloksumpan P., ne De Ruijter M., Castilho M., Gbureck U., Vermonden T., Van Weeren P.R., Malda J., Levato R. Combining multi-scale 3D printing technologies to engineer reinforced hydrogel-ceramic interfaces. Biofabrication. 2020;12 doi: 10.1088/1758-5090/ab69d9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ying G.L., Jiang N., Maharjan S., Yin Y.X., Chai R.R., Cao X., Yang J.Z., Miri A.K., Hassan S., Zhang Y.S. Aqueous two-phase emulsion bioink-enabled 3D bioprinting of porous hydrogels. Adv. Mater. 2018;30 doi: 10.1002/adma.201805460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ying G., Manríquez J., Wu D., Zhang J., Jiang N., Maharjan S., Hernández Medina D.H., Zhang Y.S. An open-source handheld extruder loaded with pore-forming bioink for in situ wound dressing. Mater. Today Bio. 2020 doi: 10.1016/j.mtbio.2020.100074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ying G., Jiang N., Parra-Cantu C., Tang G., Zhang J., Wang H., Chen S., Huang N.P., Xie J., Zhang Y.S. Bioprinted injectable hierarchically porous gelatin methacryloyl hydrogel constructs with shape-memory properties. Adv. Funct. Mater. 2020 doi: 10.1002/adfm.202003740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kwak H.W., Shin M., Lee J.Y., Yun H., Song D.W., Yang Y., Shin B.S., Park Y.H., Lee K.H. Fabrication of an ultrafine fish gelatin nanofibrous web from an aqueous solution by electrospinning. Int. J. Biol. Macromol. 2017 doi: 10.1016/j.ijbiomac.2017.04.087. [DOI] [PubMed] [Google Scholar]
- 43.Yoon H.J., Shin S.R., Cha J.M., Lee S.H., Kim J.H., Do J.T., Song H., Bae H. Cold water fish gelatin methacryloyl hydrogel for tissue engineering application. PLoS One. 2016 doi: 10.1371/journal.pone.0163902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Sánchez-Ferrero A., Mata Á., Mateos-Timoneda M.A., Rodríguez-Cabello J.C., Alonso M., Planell J., Engel E. Biomaterials; 2015. Development of Tailored and Self-Mineralizing Citric Acid-Crosslinked Hydrogels for in Situ Bone Regeneration. [DOI] [PubMed] [Google Scholar]
- 45.Bian L., Hou C., Tous E., Rai R., Mauck R.L., Burdick J.A. Biomaterials; 2013. The Influence of Hyaluronic Acid Hydrogel Crosslinking Density and Macromolecular Diffusivity on Human MSC Chondrogenesis and Hypertrophy. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Mouser V.H.M.M., Melchels F.P.W.W., Visser J., Dhert W.J.A.A., Gawlitta D., Malda J. Yield stress determines bioprintability of hydrogels based on gelatin-methacryloyl and gellan gum for cartilage bioprinting. Biofabrication. 2016;8:35003. doi: 10.1088/1758-5090/8/3/035003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Klotz B.J., Lim K.S., Chang Y.X., Soliman B.G., Pennings I., Melchels F.P.W., Woodfield T.B.F., Rosenberg A.J.W.P., Malda J., Gawlitta D. Engineering of a complex bone tissue model with endothelialised channels and capillary-like networks. Eur. Cell. Mater. 2018;35:335–349. doi: 10.22203/eCM.v035a23. [DOI] [PubMed] [Google Scholar]
- 48.Melchels F.P.W., Feijen J., Grijpma D.W. A poly(d,l-lactide) resin for the preparation of tissue engineering scaffolds by stereolithography. Biomaterials. 2009;30:3801–3809. doi: 10.1016/j.biomaterials.2009.03.055. [DOI] [PubMed] [Google Scholar]
- 49.Shin S., Kwak H., Hyun J. Melanin nanoparticle-incorporated silk fibroin hydrogels for the enhancement of printing resolution in 3D-projection stereolithography of poly(ethylene glycol)-tetraacrylate bio-ink. ACS Appl. Mater. Interfaces. 2018;10:23573–23582. doi: 10.1021/acsami.8b05963. [DOI] [PubMed] [Google Scholar]
- 50.van Hoorick J., Dobos A., Markovic M., Gheysens T., van Damme L., Gruber P., Tytgat L., van Erps J., Thienpont H., Dubruel P., Ovsianikov A., van Vlierberghe S. Biofabrication; 2020. Thiol-norbornene Gelatin Hydrogels: Influence of Thiolated Crosslinker on Network Properties and High Definition 3D Printing. [DOI] [PubMed] [Google Scholar]
- 51.Van Hoorick J., Gruber P., Markovic M., Rollot M., Graulus G.J., Vagenende M., Tromayer M., Van Erps J., Thienpont H., Martins J.C., Baudis S., Ovsianikov A., Dubruel P., Van Vlierberghe S. Highly reactive thiol-norbornene photo-click hydrogels: toward improved processability. Macromol. Rapid Commun. 2018;39 doi: 10.1002/marc.201800181. [DOI] [PubMed] [Google Scholar]
- 52.Zhong Z., Deng X., Wang P., Yu C., Kiratitanaporn W., Wu X., Schimelman J., Tang M., Balayan A., Yao E., Tian J., Chen L., Zhang K., Chen S. Biomaterials; 2021. Rapid Bioprinting of Conjunctival Stem Cell Micro-constructs for Subconjunctival Ocular Injection. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Kim S.H., Yeon Y.K., Lee J.M., Chao J.R., Lee Y.J., Seo Y.B., Sultan M.T., Lee O.J., Lee J.S., Il Yoon S., Hong I.S., Khang G., Lee S.J., Yoo J.J., Park C.H. Precisely printable and biocompatible silk fibroin bioink for digital light processing 3D printing. Nat. Commun. 2018;9 doi: 10.1038/s41467-018-03759-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Jang J., Kim T.G., Kim B.S., Kim S.W., Kwon S.M., Cho D.W. Tailoring mechanical properties of decellularized extracellular matrix bioink by vitamin B2-induced photo-crosslinking. Acta Biomater. 2016;33:88–95. doi: 10.1016/j.actbio.2016.01.013. [DOI] [PubMed] [Google Scholar]
- 55.Huh J.T., Moon Y.W., Park J., Atala A., Yoo J.J., Lee S.J. Biofabrication; 2021. Combinations of Photoinitiator and UV Absorber for Cell-Based Digital Light Processing (DLP) Bioprinting. [DOI] [PubMed] [Google Scholar]
- 56.Wang Y., Wang Y., Mei D. Scalable printing of bionic multiscale channel networks through digital light processing-based three-dimensional printing process. 3D Print. Addit. Manuf. 2020 doi: 10.1089/3dp.2020.0025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Zhang R., Larsen N.B. Stereolithographic hydrogel printing of 3D culture chips with biofunctionalized complex 3D perfusion networks. Lab Chip. 2017;17:4273–4282. doi: 10.1039/c7lc00926g. [DOI] [PubMed] [Google Scholar]
- 58.Urrios A., Parra-Cabrera C., Bhattacharjee N., Gonzalez-Suarez A.M., Rigat-Brugarolas L.G., Nallapatti U., Samitier J., Deforest C.A., Posas F., Garcia-Cordero J.L., Folch A. 3D-printing of transparent bio-microfluidic devices in PEG-DA. Lab Chip. 2016 doi: 10.1039/c6lc00153j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Ma X., Qu X., Zhu W., Li Y.S., Yuan S., Zhang H., Liu J., Wang P., Lai C.S.E., Zanella F., Feng G.S., Sheikh F., Chien S., Chen S. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting. Proc. Natl. Acad. Sci. U.S.A. 2016 doi: 10.1073/pnas.1524510113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Soliman B.G., Lindberg G.C.J., Jungst T., Hooper G.J., Groll J., Woodfield T.B.F., Lim K.S. Stepwise control of crosslinking in a one-pot system for bioprinting of low-density bioinks. Adv. Healthc. Mater. 2020 doi: 10.1002/adhm.201901544. [DOI] [PubMed] [Google Scholar]
- 61.Zhou F., Hong Y., Liang R., Zhang X., Liao Y., Jiang D., Zhang J., Sheng Z., Xie C., Peng Z., Zhuang X., Bunpetch V., Zou Y., Huang W., Zhang Q., Alakpa E.V., Zhang S., Ouyang H. Biomaterials; 2020. Rapid Printing of Bio-Inspired 3D Tissue Constructs for Skin Regeneration. [DOI] [PubMed] [Google Scholar]
- 62.Bornes T.D., Adesida A.B., Jomha N.M. Mesenchymal stem cells in the treatment of traumatic articular cartilage defects: a comprehensive review. Arthritis Res. Ther. 2014;16:432. doi: 10.1186/s13075-014-0432-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Mancini I.A.D., Schmidt S., Brommer H., Pouran B., Schäfer S., Tessmar J., Mensinga A., Van Rijen M.H.P., Groll J., Blunk T., Levato R., Malda J., Van Weeren P.R. Biofabrication; 2020. A Composite hydrogel-3D Printed Thermoplast Osteochondral Anchor as Example for a Zonal Approach to Cartilage Repair: in Vivo Performance in a Long-Term Equine Model. [DOI] [PubMed] [Google Scholar]
- 64.Visser J., Gawlitta D., Benders K.E.M., Toma S.M.H., Pouran B., van Weeren P.R., Dhert W.J.A., Malda J. Endochondral bone formation in gelatin methacrylamide hydrogel with embedded cartilage-derived matrix particles. Biomaterials. 2015;37:174–182. doi: 10.1016/j.biomaterials.2014.10.020. [DOI] [PubMed] [Google Scholar]
- 65.Kumar H., Sakthivel K., Mohamed M.G.A., Boras E., Shin S.R., Kim K. Designing gelatin methacryloyl (GelMA)-Based bioinks for visible light stereolithographic 3D biofabrication. Macromol. Biosci. 2021 doi: 10.1002/mabi.202000317. [DOI] [PubMed] [Google Scholar]
- 66.Kinstlinger I.S., Calderon G.A., Royse M.K., Means A.K., Grigoryan B., Miller J.S. Perfusion and endothelialization of engineered tissues with patterned vascular networks. Nat. Protoc. 2021 doi: 10.1038/s41596-021-00533-1. [DOI] [PubMed] [Google Scholar]
- 67.Corbett D.C., Fabyan W.B., Grigoryan B., O'Connor C.E., Johansson F., Batalov I., Regier M.C., DeForest C.A., Miller J.S., Stevens K.R. Thermofluidic heat exchangers for actuation of transcription in artificial tissues. Sci. Adv. 2020 doi: 10.1126/sciadv.abb9062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Klotz B.J., Gawlitta D., Rosenberg A.J.W.P., Malda J., Melchels F.P.W. Gelatin-methacryloyl hydrogels: towards biofabrication-based tissue repair. Trends Biotechnol. 2016;34:394–407. doi: 10.1016/j.tibtech.2016.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Gauvin R., Chen Y.C., Lee J.W., Soman P., Zorlutuna P., Nichol J.W., Bae H., Chen S., Khademhosseini A. Microfabrication of complex porous tissue engineering scaffolds using 3D projection stereolithography. Biomaterials. 2012;33:3824–3834. doi: 10.1016/j.biomaterials.2012.01.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Chen P., Zheng L., Wang Y., Tao M., Xie Z., Xia C., Gu C., Chen J., Qiu P., Mei S., Ning L., Shi Y., Fang C., Fan S., Lin X. Theranostics; 2019. Desktop-stereolithography 3D Printing of a Radially Oriented Extracellular Matrix/mesenchymal Stem Cell Exosome Bioink for Osteochondral Defect Regeneration. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Ye W., Li H., Yu K., Xie C., Wang P., Zheng Y., Zhang P., Xiu J., Yang Y., Zhang F., He Y., Gao Q. 3D printing of gelatin methacrylate-based nerve guidance conduits with multiple channels. Mater. Des. 2020 doi: 10.1016/j.matdes.2020.108757. [DOI] [Google Scholar]
- 72.Colosi C., Shin S.R., Manoharan V., Massa S., Costantini M., Barbetta A., Dokmeci M.R., Dentini M., Khademhosseini A. Microfluidic bioprinting of heterogeneous 3D tissue constructs using low-viscosity bioink. Adv. Mater. 2016;28:677–684a. doi: 10.1002/adma.201503310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Fazal F., Raghav S., Callanan A., Koutsos V., Radacsi N. Biofabrication; 2021. Recent Advancements in the Bioprinting of Vascular Grafts. [DOI] [PubMed] [Google Scholar]
- 74.Kolesky D.B., Truby R.L., Gladman A.S., Busbee T.A., Homan K.A., Lewis J.A. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv. Mater. 2014;26:3124–3130. doi: 10.1002/adma.201305506. [DOI] [PubMed] [Google Scholar]
- 75.Zhang Y.S., Davoudi F., Walch P., Manbachi A., Luo X., Dell'Erba V., Miri A.K., Albadawi H., Arneri A., Li X., Wang X., Dokmeci M.R., Khademhosseini A., Oklu R. Bioprinted thrombosis-on-a-chip. Lab Chip. 2016;16:4097–4105. doi: 10.1039/c6lc00380j. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.